Friday
SESSION 77: CAS Vs. CEA RELATED TOPICS: THE FUTURE FOR CAS IS BRIGHT
Moderators:Ross Naylor, MD, FRCS / Frank J. Veith, MD  
SESSION 77 SCHEDULE
10:10 AM - 10:15 AM Despite Various Claims, What Is The Current Truth About The Effects Of CAS And CEA On Cognitive Function: Is There A Difference Between The Procedures
  Presenter(s):Kosmas I. Paraskevas, MD  
  View Abstract      
10:16 AM - 10:21 AM Carotid Procedures (CEA Or CAS) For Acute Stroke: When Should They Be Done And How
  Presenter(s):Laura Capoccia, MD, PhD  
  View Abstract      
10:22 AM - 10:27 AM Outcome Of A High Risk Plaque Study In 6100 Americans: What Does It Tell Us
  Presenter(s):Henrik Sillesen, MD, DMSc  
  View Abstract      
10:28 AM - 10:33 AM The Truth About The High Risk Carotid Patient And Which Patients Should Be Enrolled In Future Carotid Trials
  Presenter(s):Gerrit J. de Borst, MD  
  View Abstract      
10:34 AM - 10:39 AM Long-Term Stroke Risk After CEA Has Been Lower Than After CAS: Based On VQI And Medicare US Population-Wide Data
  Presenter(s):Philip P. Goodney, MD, MS  
  View Abstract      
10:40 AM - 10:45 AM DEBATE: CMS (Medicare) Should Expand Reimbursement For CAS Indications To Include Average Risk Symptomatic And Asymptomatic Carotid Stenosis Patients
  Presenter(s):William A. Gray, MD  
  View Abstract      
10:46 AM - 10:51 AM DEBATE: CMS Should Not Expand Reimbursement For CAS Indications To Include Average Risk Symptomatic And Asymptomatic Carotid Stenosis Patients
  Presenter(s):Wesley S. Moore, MD  
  View Abstract      
10:52 AM - 10:57 AM Will Recent Improvements In Medical Therapy Lower Stroke Risk In Asymptomatic Carotid Stenosis Patients So Much That Further Treatment Will Be Unnecessary: Are The ACST And ACSRS Studies Now Obsolete And Will They Have To Be Done Again: Is There A High Risk Asymptomatic Patient Group That Will Benefit From CEA Or CAS
  Presenter(s):Andrew N. Nicolaides, MS / Stavros Kakkos, MD, PhD  
  View Abstract      
10:58 AM - 11:05 AM Panel Discussion
THE FUTURE FOR CAS IS BRIGHT
Moderator(s): Thomas G. Brott, MD / Wesley S. Moore, MD  
11:05 AM - 11:10 AM Why CAS Will Have A Renaissance And What Studies Are Needed To Justify It: The Mesh Covered Scaffold Stent (Gore) Should Help
  Presenter(s):Peter A. Schneider, MD  
  View Abstract      
11:11 AM - 11:16 AM How To Improve CAS And Prevent Post-Procedural Strokes After CAS: Clinical Experience With The Roadsaver Micromesh Carotid Stent: How Does The Micromesh Stent Compare To Other Mesh-Covered Stents Like The MicroNet (C-Guard) Stent From InspireMD And the Scaffold Stent From Gore
  Presenter(s):Max Amor, MD  
  View Abstract      
11:17 AM - 11:22 AM A New Development In CAS Which Will Improve Results: Is The Cervical Flow Reversal Device (Michi System) From Silk Road The Safest Way To Perform CAS: When Will We Know How Well It Works
  Presenter(s):Christopher J. Kwolek, MD / Richard P. Cambria, MD  
  View Abstract      
11:23 AM - 11:28 AM What Is The Pathological And Functional Significance Of Diffusion Weighted MRI (DW MRI) Defects After CEA And CAS: Are They Irrelevant Or A Bad Thing
  Presenter(s):Emmanuel M. Houdart, MD  
  View Abstract      
INTENSIVE MEDICAL THERAPY WITH PROPER STATIN USAGE ETC. IS A DISRUPTIVE INFLUENCE
11:29 AM - 11:34 AM Intensive Medical Therapy With Proper Statin Usage Etc. Is A Disruptive Influence
  Presenter(s):Thomas G. Brott, MD  
  View Abstract      
11:35 AM - 11:40 AM The CREST Trial Did Not Optimize Medical Treatment And Risk Factor Control Especially In the CEA Treated Patients: What Are The Implications
  Presenter(s):Carlos H. Timaran, MD  
  View Abstract      
11:41 AM - 11:46 AM How Will ACST 2, SPACE 2 And CREST 2 Change The CAS vs. CEA Game
  Presenter(s):Francesco Setacci, MD / Carlo Setacci, MD  
  View Abstract      
11:47 AM - 11:52 AM What Will The ECST-2 Trial Tell Us About CEA, CAS And Medical Treatment: What Is The Significance Of White Matter And Other MRI Lesions
  Presenter(s):Martin M. Brown, MD  
  View Abstract      
11:53 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 77
previous next